awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27003304-96B5A136-0C66-4EED-9B3A-72B45A9743FB
Q27003304-96B5A136-0C66-4EED-9B3A-72B45A9743FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27003304-96B5A136-0C66-4EED-9B3A-72B45A9743FB
Incidence and risk of sorafenib-induced hypertension: a systematic review and meta-analysis
P2860
Q27003304-96B5A136-0C66-4EED-9B3A-72B45A9743FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27003304-96B5A136-0C66-4EED-9B3A-72B45A9743FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6be09557a0a882a8cd3dc7841b1676682252c44e
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.